J&J | Betriebsergebnis



Operating Profit Veränderung Datum
AbbVie USD -1490000000 5.32B 2024-12
Abbott USD 1.91B 41M 2024-12
Amgen USD 2.31B 182M 2024-12
AstraZeneca USD 2.04B 731M 2024-12
Baxter International USD -435000000 590M 2024-12
Bayer EUR 3.53B 7.35B 2024-12
Becton, Dickinson and Co. USD 453M 195M 2024-12
Biogen USD 441.4M 24.4M 2024-12
Boston Scientific USD 675M 58M 2024-12
Bristol-Myers Squibb USD 793M 1.39B 2024-12
CONMED USD 52.5M 13.21M 2024-12
Cooper Companies USD 182M 16.4M 2025-01
Dexcom USD 188.9M 36.9M 2024-12
Edwards Lifesciences USD 312.6M 38M 2024-12
Eli Lilly USD 5.15B 3.62B 2024-12
Gilead Sciences USD 2.45B 1.56B 2024-12
GlaxoSmithKline GBP 696M 507M 2024-12
Globus Medical USD 60.27M 12.18M 2024-12
Hologic USD 229.8M 200K 2024-12
Indivior 94M 226M 2024-09
Insulet USD 109.3M 21.2M 2024-12
Integra LifeSciences USD 35.23M 43.36M 2024-12
Intuitive Surgical USD 734.9M 157.6M 2024-12
J&J USD 3.89B 549M 2024-12
Medtronic USD 1.65B 51M 2025-01
Merck USD 4.3B 369M 2024-12
Merit Medical Systems USD 36.56M 697K 2024-12
Novartis USD 2.28B 1.34B 2024-12
Pfizer USD -409000000 5.57B 2024-12
Regeneron Pharmaceuticals USD 990.2M 189.3M 2024-12
Roche Holding CHF 4.39B 1.04B 2024-12
Sanofi EUR 4.09B 1.81B 2024-09
Stryker USD 581M 504M 2024-12
Tandem Diabetes Care USD -582000 25.51M 2024-12
Teva Pharmaceutical Industries USD 455M 506M 2024-12
Vertex Pharmaceuticals USD 1.03B 90.3M 2024-12
Zimmer Biomet Holdings USD 389M 109.5M 2024-12
Zoetis USD 732M 142M 2024-12



J&J Betriebsergebnis - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Mar 2025.